Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIRAGLUTIDE IN OVERWEIGHT PATIENTS WITH TYPE 1 DIABETES

NCT01753362 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.

NCT NCT01753362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIRAGLUTIDE IN OVERWEIGHT PATIENTS WITH TYPE 1 DIABETES
Lead sponsor
University at Buffalo
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
February 28, 2018
Enrollment
84 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes